Arctic Bioscience AS

OB:ABS Stock Report

Market Cap: NOK 96.8m

Arctic Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABS?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,244,7578.33%
Individual Insiders4,813,66917.9%
Private Companies9,536,81135.4%
General Public10,361,01938.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Tore Andreas Tonseth
3,087,999NOK 11.1m0%no data
5.73%
Capra Invest AS
1,544,450NOK 5.5m0%no data
4.87%
Mrfk Holding As
1,313,960NOK 4.7m0%no data
4.17%
JPMorgan Chase & Co.
1,123,139NOK 4.0m-4.77%no data
3.86%
Jan Vartdal
1,040,286NOK 3.7m0%no data
2.98%
Brødrene Vartdal AS
803,601NOK 2.9m0%no data
2.48%
Kotler Equity Investment (Dong Guan) Limited
667,330NOK 2.4m0%no data
2.25%
Hawk Infinity AS
605,201NOK 2.2m0%100.0%
2.23%
Stette Invest AS
602,375NOK 2.2m0%no data
2.13%
KjølÅS Stansekniver As
574,859NOK 2.1m0%no data
2.07%
Life Capitol A.S.
558,531NOK 2.0m0%no data
2.06%
Ajea Invest AS
555,359NOK 2.0m0%no data
1.93%
Pme As
520,240NOK 1.9m0%no data
1.92%
Nordnet Pensionsförsäkring AB
516,417NOK 1.9m25.4%0.02%
1.76%
Strand Fiskeriselskap As
473,342NOK 1.7m0%no data
1.71%
Hogne Hallaraker
460,000NOK 1.7m-1.08%no data
1.46%
Altitude Capital AS
394,455NOK 1.4m0%1.64%
1.26%
Koppernæs Protein AS
340,000NOK 1.2m0%no data
1.17%
Melesio Invest As
315,000NOK 1.1m0%no data
1.09%
Em-Ka AS
292,771NOK 1.1m0%no data
0.94%
Høgnabben As
252,949NOK 908.1k0%no data
0.93%
Norholmen As
251,409NOK 902.6k0%no data
0.28%
Futuron As
76,180NOK 273.5k0%no data
0.22%
Daniele Mancinelli
58,840NOK 211.2k0%no data
0.21%
Christer Valderhaug
57,630NOK 206.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/05 12:13
End of Day Share Price 2026/01/05 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arctic Bioscience AS is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrik LingDNB Carnegie
Geir HolomDNB Carnegie